Fig. 2From: Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experienceKaplan Meier curve of percentage of sustained MMR after discontinuation. a In the overall population, two-year estimate: 82%, 95% CI [72, 89]. b Excluding patients who resumed therapy before losing MMR, 2-year estimate: 79%, 95% CI [67, 87]Back to article page